Related Experiment Videos
Acetazolamide responsive hereditary paroxysmal ataxia
1Roger Williams General Hospital, Providence, Rhode Island 02908.
Summary
Acetazolamide effectively treats autosomal dominant paroxysmal ataxia, a rare neurological disorder. This study details a fourteenth family experiencing this condition, confirming acetazolamide
Area of Science:
- Neurology
- Genetics
- Pharmacology
Background:
- Describes the fourteenth family diagnosed with autosomal dominant paroxysmal ataxia.
- Highlights the rarity and genetic nature of this neurological disorder.
Observation:
- Patients experience recurrent episodes of ataxia.
- Symptoms are consistent with previously documented families with this condition.
Findings:
- Acetazolamide administration resulted in complete resolution of ataxia episodes.
- Confirms the efficacy of acetazolamide in treating this specific genetic ataxia.
Implications:
- Suggests a potential therapeutic mechanism for acetazolamide in managing paroxysmal ataxia.
- Provides further evidence for acetazolamide as a first-line treatment option.
- Contributes to understanding the pathophysiology of autosomal dominant paroxysmal ataxia.